DiaSorin S.p.A.

DIA

IT0003492391

Medical Equipment, Supplies & Distribution

Real-time Borsa Italiana Other stock markets 05:19:38 2024-09-18 am EDT			5-day change	1st Jan Change
101.45 ^EUR	-1.46%		-1.74%	+8.81%

Sep. 17	Marshall Wace cuts short Snam and OVS.	AN
Sep. 16	Futures cautious in Fed, BoE and BoJ week	AN

This Alphavalue article, the European leader in independent research, is only available to subscribers .

Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about DiaSorin S.p.A.

Marshall Wace cuts short Snam and OVS.	Sep. 17	AN
Futures cautious in Fed, BoE and BoJ week	Sep. 16	AN
Mib closes up slightly; now focus on Fed	Sep. 13	AN
Stock exchanges up; Eurozone industrial production falls	Sep. 13	AN
Business Square up; UK unemployment falls	Sep. 10	AN
Futures little moved; Germany inflation at 1.9 percent	Sep. 10	AN
Mib up, traders await central banks	Sep. 09	AN
DiaSorin launches new Liaison antigen test in countries with CE	Sep. 09	AN
Indices up; EU recession fears for Sentix	Sep. 09	AN
Indices up; UniCredit tops the Mib	Sep. 09	AN
Funds move on Iveco, DiaSorin and STM.	Sep. 06	AN
Stock exchanges in the red at start; oil weighed down	Sep. 05	AN
Funds operate on BPER, DiaSorin, Italgas and Saipem.	Sep. 04	AN
Lists up tentatively; traders await data	Sep. 03	AN
Mib in red; Leonardo ends at bottom	Sep. 02	AN
Milan stock market weak, session without cues with WS closed, banks good, Juve slumps on realizations	Sep. 02	RE
Futures await contrasting stock markets	Aug. 29	AN
Mib advances to 33,800; Recordati and DiaSorin on top	Aug. 28	AN
Milan bullish; DiaSorin takes top spot	Aug. 28	AN
Stock markets in green ahead of Powell; banks good on Mib	Aug. 23	AN
DiaSorin, annulment of administrative penalty imposed by CONSOB	Aug. 23	AN
Global markets live: Diageo, Apple, Tesla, Meta Platforms, PayPal, Pfizer...	Jul. 30
DIASORIN : Q2 profitability beat; lower end of guidance upgraded	Jul. 30
Piazza Affari up; Campari hurt after accounts	Jul. 30	AN
Mib in green; half-yearly publication pushes Poste	Jul. 30	AN

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Employees

3,186

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-11-14 - Q3 2024 Earnings Release

More about the company